News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
11-Feb-2010 - Sanofi-aventis announced that it has successfully completed its tender offer for all outstanding shares of common stock of Chattem, Inc. The tender offer and withdrawal rights expired at 12:00 midnight, New York City time, on February 8, 2010. The depositary for the tender offer has advised ...
29-Jan-2010 - Cellectis S.A. has won a National Innovation Award from the French National Institute for Industrial Property (INPI). Cellectis IP Manager Michèle Paquier received the award from Thierry Morin, President of the INPI Board, during a ceremony at the Pavillon Gabriel venue in Paris. The awards, ...
25-Jan-2010 - Bioamber, a joint venture between US-based DNP Green Technology andFrance-based ARD (Agro-industrie Recherches et Développements), announces the successful start-up and commissioning of the world's first bio-based succinic acid plant. Since December 2009, the plant has been producing renewable ...
15-Jan-2010 - Cellectis S.A. has announced that Bayer HealthCare has acquired a license to use Cellectis’ patent family WO9011354 covering homologous recombination aimed to introduce new features into the genome. This global license includes the use of the Institut Pasteur technology relating to homologous ...
23-Dec-2009 - NicOx S.A. announced that it has raised a total of approximately €100 million via a two-step capital increase. The second step of this capital increase was the completion of a rights issue, launched on November 25th 2009, which raised total gross proceeds of €69.9 million through the issuance of ...
23-Dec-2009 - DBV Technologies (DBV) announced the appointment of US-based food allergy and paediatric asthma specialist Professor Robert Zeiger to its Scientific Advisory Board. In joining the Scientific Advisory Board, Professor Zeiger will provide DBV Technologies’ with access to his expertise in food ...
23-Dec-2009 - NicOx S.A. announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). This follows the ...
04-Dec-2009 - Transgene announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track development designation to its immunotherapy product TG4010 (MVA-MUC1-IL2) for the first-line treatment of advanced non-small cell lung cancer (NSCLC) in combination with chemotherapy. The FDA determined ...
01-Dec-2009 - Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure.Germany, the first country where Oralair(R) has been marketed, was the reference Member state. Oralair(R) is now registered in Austria, Belgium, Bulgaria, ...
26-Nov-2009 - GENFIT announced positive results in Phase II with its most advanced drug candidate, GFT505, in prediabetic patients with atherogenic dyslipidemia and abdominal obesity (study GFT505-2083). Analysis of the results of this clinical trial showed that GFT505 was very well tolerated at the dose of ...
© 1997-2024 LUMITOS AG, All rights reserved